Novo Nordisk A/S
NOVO-B
Rank in Stocks
#107
Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the... Novo Nordisk A/S operates as a global healthcare enterprise, dedicated to the innovation, development, production, and commercialization of pharmaceutical solutions. Its business is primarily divided into two key segments: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care segment offers a comprehensive portfolio of treatments for diabetes (including insulins, GLP-1 analogues, oral antidiabetic agents, and related delivery systems), obesity management, glucagon, medical needles, and other chronic conditions. The Rare Disease segment provides specialized medications for haemophilia, various blood disorders, endocrine imbalances, growth hormone deficiencies, and hormone replacement therapy. Additionally, the company engages in strategic alliances, including a partnership with Gilead Sciences, Inc., and conducts research focused on identifying cell-specific carriers for nucleic acid-based therapies. Established in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.
Share Price
$39.74
Market Cap
$175.38B
Change (1 day)
1.28%
Change (1 year)
-25.58%
Country
DK
Trade Novo Nordisk A/S (NOVO-B)
Category
Healthcare
Stock price history for Novo Nordisk A/S (NOVO-B)
Highest end of day price: $40.26 on 2026-10-01
Lowest end of day price: $0.14 on 1988-03-01
Lowest end of day price: $0.14 on 1988-03-01
Stock price history of Novo Nordisk A/S from 1988 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -4.45% |
| 2025 | -53.02% |
| 2024 | 4.21% |
| 2023 | 52.47% |
| 2022 | 18.08% |
| 2021 | 58.61% |
| 2020 | 21.95% |
| 2019 | 25.17% |
| 2018 | -13.06% |
| 2017 | 48.68% |
| 2016 | -37.84% |
| 2015 | 27.24% |
| 2014 | 25.46% |
| 2013 | 10.41% |
| 2012 | 42.79% |
| 2011 | 5.24% |
| 2010 | 62.58% |
| 2009 | 28.20% |
| 2008 | -21.04% |
| 2007 | 59.27% |
| 2006 | 48.38% |
| 2005 | 2.70% |
| 2004 | 38.02% |
| 2003 | 32.64% |
| 2002 | -24.80% |
| 2001 | 5.84% |
| 2000 | 40.15% |
| 1999 | 7.14% |
| 1998 | -13.94% |
| 1997 | 67.94% |
| 1996 | 44.54% |
| 1995 | 33.16% |
| 1994 | -12.19% |
| 1993 | 12.92% |
| 1992 | 8.32% |
| 1991 | 54.12% |
| 1990 | 3.96% |
| 1989 | 25.86% |
| 1988 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $1.31K | 61.21% |
US
|
|
| $268.35 | 39.08% |
US
|
|
| $284.58 | 24.44% |
US
|
|
| $147.45 | 68.30% |
US
|
|
| $482.01 | 30.76% |
CH
|
